Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

Rule 8.3- Expro Intnl

7 May 2008 14:20

Baillie Gifford & Co.07 May 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) Baillie Gifford Company dealt in Expro Intl. Grp. Class of relevant security to which Ordinary Shares the dealings being disclosed relate (Note 2) Date of dealing 06/05/08 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 5,423,733 5.47 (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 5,423,733 5.47 (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 12,256 1516.0p (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. ................................................................................ ................................................................................ Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 07/05/08 Contact name Amee Yostrakul Telephone number 0131 275 3047 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM
16th May 20224:11 pmRNSNotice of AGM, Posting of Annual Report & Accounts
7th Apr 20224:40 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSEngage and Victory XR to Launch 10 Metaversities
28th Mar 20227:00 amRNSNew Senior Appointments to help drive US Growth
8th Mar 20227:01 amRNSFinal Results
4th Mar 202211:30 amRNSAIM Rule 17 Schedule 2(g) Update
16th Feb 20227:00 amRNSNotice of Results & Investor Presentation
31st Jan 20227:00 amRNSPre-Close Trading Update & Directorate Change
23rd Nov 20217:00 amRNSDirectorate Changes
12th Nov 20217:00 amRNSENGAGE Update & Investor Presentation
5th Nov 202110:24 amRNSExercise of Options
1st Jul 20081:02 pmRNSDirector Dealings
1st Jul 200811:16 amRNSScheme Effective
30th Jun 20085:52 pmRNSHolding(s) in Company
30th Jun 20083:03 pmRNSRule 8.3- Expro International
30th Jun 20082:19 pmBUSRule 8.3 - Expro International
30th Jun 200812:52 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:42 pmRNSEPT Disclosure - Expro Intl G
30th Jun 200812:37 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:11 pmRNSRule 8.3- Expro International
30th Jun 200811:16 amRNSHolding(s) in Company
30th Jun 200811:03 amRNSScheme of arrangement
27th Jun 20085:01 pmRNSRule 2.10 Announcement
27th Jun 20085:00 pmRNSSuspension - Expro Internatio
27th Jun 20084:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.